pregnant while on tirzepatide Semaglutide and Impact Conception Does Tirzepatide Make You Fertile?

The 12mg weekly maintenance dose produced the greatest weight reduction (-24.2%) in Phase 2 trials

Emerging reports suggest that GLP-1 medications, such as Ozempic and Wegovy, may impair fertility in both men and women, raising potential implications for future product liability claims

These programs are most valuable for patients with complex metabolic conditions who benefit from close, coordinated monitoring over time

Tirzepatide functions as a dual agonist, targeting both GLP-1 and GIP receptors to further maximize cellular insulin sensitivity and lipolysis (breaking down fat)

These results emphasize the importance of integrating HZ immunization into the routine care of diabetic patients on GLP-1RA therapy, especially for those with suboptimal glycemic control

Before recommending semaglutide, tirzepatide, or another medically supervised weight-loss strategy, a physician may review weight history, prior weight-loss attempts, BMI, waist circumference, body composition goals, A1C, fasting glucose, insulin-resistance risk, cholesterol, triglycerides, blood pressure, liver enzymes, fatty liver risk, kidney function, current medications, diabetes medication use, history of pancreatitis, gallbladder disease, gastrointestinal symptoms, thyroid history, protein intake, exercise habits, sleep quality, hormonal symptoms, inflammation-related concerns, side-effect tolerance, and long-term maintenance planning